Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Joint, bone, spine : revue du rhumatisme

• Publication date

  2017-12-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jbspin.2017.12.009PMID 29288864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls

  2017cited by this paper
• Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus

  2016cited by this paper
• Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention

  2016cited by this paper
• Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France.

  2016cited by this paper
• Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review

  2016cited by this paper
• Intima-media thickness in secondary anti-phospholipid syndrome patients: Impact of disease activity

  2015cited by this paper
• Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques - a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness

  2015cited by this paper
• AB0584 Subclinical Atheromatosis in Patients with Systemic Lupus Erythematosus

  2015cited by this paper
• Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study

  2015cited by this paper
• Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques--a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness.

  2015cited by this paper
• Metabolic Syndrome Is Correlated With Carotid Atherosclerosis in Patients With Lupus Nephritis

  2014cited by this paper
• Decreased Flow-Mediated Dilatation in Patients with Systemic Lupus Erythematosus: a Meta-analysis

  2014cited by this paper
• Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1

  2014cited by this paper
• Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome: Focus on &bgr;2GPI-Specific T Cell Response

  2014cited by this paper
• Impaired endothelial function in patients with Takayasu’s arteritis

  2014cited by this paper
• Prognostic value of flow-mediated dilation in patients with systemic lupus erythematosus: a pilot prospective cohort study.

  2014cited by this paper
• Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients

  2014cited by this paper
• Carotid intima-media thickness and cardiovascular disease risk prediction.

  2014cited by this paper
• Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus

  2013cited by this paper
• Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients.

  2013cited by this paper
• Reduced carotid intima–media thickness in systemic lupus erythematosus patients treated with cyclosporine A

  2013cited by this paper
• Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

  2012cited by this paper
• Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.

  2012cited by this paper
• Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data.

  2012cited by this paper
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Resistin in systemic lupus erythematosus: Relation to lupus nephritis and premature atherosclerosis

  2012cited by this paper
• Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011)

  2012cited by this paper
• Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients.

  2011cited by this paper
• Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.

  2011cited by this paper
• Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.

  2011cited by this paper
• Carotid intima–media thickness: a suitable alternative for cardiovascular risk as outcome?

  2011cited by this paper
• Influence of pregnancy and smoking on brachial artery flow-mediated dilation values and time until maximum response

  2011cited by this paper
• Endothelium-dependent But Not Endothelium-independent Flow-mediated Dilation Is Significantly Reduced in Patients with Systemic Lupus Erythematosus without Vascular Events: A Metaanalysis and Metaregression

  2011cited by this paper
• The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus.

  2010cited by this paper
• Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

  2010cited by this paper
• Rheumatic Disease and Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2010cited by this paper
• Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus.

  2010cited by this paper
• Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus

  2009cited by this paper
• Arterial wall dysfunction in systemic lupus erythematosus

  2009cited by this paper
• Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus.

  2009cited by this paper
• A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus

  2009cited by this paper
• Endothelial dysfunction in Iranian lupus patients

  2009cited by this paper
• The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus

  2009cited by this paper
• Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus.

  2008cited by this paper
• Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

  2008cited by this paper
• Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis.

  2008cited by this paper
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Carotid Intima-Media Thickening Indicates a Higher Vascular Risk Across a Wide Age Range: Prospective Data From the Carotid Atherosclerosis Progression Study (CAPS)

  2006cited by this paper
• Mortality in systemic lupus erythematosus.

  2006cited by this paper
• Mannheim Carotid Intima-Media Thickness Consensus (2004–2006)

  2006cited by this paper
• 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.

  2005cited by this paper
• Arterial Stiffness in Chronic Inflammatory Diseases

  2005cited by this paper
• Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus.

  2004cited by this paper
• Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.

  2004cited by this paper
• Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

  2003cited by this paper
• Early-Onset Carotid Atherosclerosis Is Associated With Increased Intima-Media Thickness and Elevated Serum Levels of Inflammatory Markers

  2003cited by this paper
• Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

  2002cited by this paper
• Brachial endothelial function is impaired in patients with systemic lupus erythematosus.

  2002cited by this paper
• Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide.

  1999cited by this paper
• Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.

  1999cited by this paper
• Close relation of endothelial function in the human coronary and peripheral circulations.

  1995cited by this paper
• Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

  1992cited by this paper
• Coronary Artery Disease Risk Factors in the Johns Hopkins Lupus Cohort: Prevalence, Recognition by Patients, and Preventive Practices

  1992cited by this paper
• Mortality in systemic lupus erythematosus.

  1987cited by this paper
• The bimodal mortality pattern of systemic lupus erythematosus.

  1976cited by this paper

• Exploring endothelial dysfunction in major rheumatic diseases: current trends and future directions

  2025cites this paper
• Early Atherosclerosis in Pediatric Systemic Lupus Erythematosus: A Systematic Review and Meta‐Analysis

  2025influential citation
• Comparison of carotid intima-media thickness and cognitive function in systemic lupus erythematosus patients versus healthy subjects

  2025cites this paper
• Ultrasound in rheumatic and musculoskeletal diseases: from musculoskeletal to organ involvement.

  2025cites this paper
• Accumulation of Microvascular Target Organ Damage in Systemic Lupus Erythematosus Patients Is Associated with Increased Cardiovascular Risk

  2024cites this paper
• Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission

  2024cites this paper
• Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE

  2023cites this paper
• Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease

  2023cites this paper
• Accelerated atherosclerosis and management of cardiovascular risk in autoimmune rheumatic diseases: an updated review.

  2023cites this paper
• Insulin Resistance in Patients with Lupus Nephritis: Association to Cardiovascular Risk Factors, Disease Activity, and Subclinical Atherosclerosis

  2023cites this paper
• The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus

  2023cites this paper
• Asymptomatic coronary artery disease assessed by coronary computed tomography in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

  2022cites this paper
• Coronary plaque progression is greater in systemic lupus erythematosus than rheumatoid arthritis

  2022cites this paper
• Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review

  2022cites this paper
• Resveratrol protects against atherosclerosis by downregulating the PI3K/AKT/mTOR signaling pathway in atherosclerosis model mice

  2022cites this paper
• Qinghao-Biejia Herb Pair Alleviates Pristane-Induced Lupus-Like Disease and Associated Renal and Aortic Lesions in ApoE−/− Mice

  2022cites this paper
• Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study

  2021cites this paper
• Retracted: Effect of dipeptidyl peptidase‐4 inhibitors on the progression of atherosclerosis in patients with type 2 diabetes mellitus: A meta‐analysis of randomised controlled trials

  2021cites this paper
• Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?

  2021cites this paper
• Study of Cardiovascular Diseases Risk in Systemic Lupus Erythematosus Can Be Comparable with Type 2 Diabetes Mellitus

  2021cites this paper
• Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus

  2021cites this paper
• Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation

  2021cites this paper
• Impaired Microcirculation and Vascular Hemodynamics in Relation to Macrocirculation in Patients With Systemic Lupus Erythematosus

  2021cites this paper
• CARDIOVASCULAR CONSEQUENCES OF AUTOIMMUNE RHEUMATIC DISEASES.

  2020cites this paper
• High-Frequency Ultrasound of Multiple Arterial Areas Reveals Increased Intima Media Thickness, Vessel Wall Appearance, and Atherosclerotic Plaques in Systemic Lupus Erythematosus

  2020cites this paper
• Pterostilbene reduces endothelial cell apoptosis by regulation of the Nrf2-mediated TLR-4/MyD88/NF-κB pathway in a rat model of atherosclerosis

  2020cites this paper
• Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients

  2020cites this paper
• Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China

  2019cites this paper
• Correlation between Osteoprotegerin Levels and Antiphospholipid Syndrome Parameters.

  2019cites this paper
• Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving Story

  2019cites this paper
• B cells and atherosclerosis in systemic lupus erythematosus

  2019cites this paper
• Serum osteopontin negatively impacts on intima‐media thickness in patients with systemic lupus erythematosus

  2019cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention.

  2019cites this paper
• Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease

  2019cites this paper
• Pterostilbene reduces endothelial cell injury in vascular arterial walls by regulating the Nrf2-mediated AMPK/STAT3 pathway in an atherosclerosis rat model

  2019cites this paper
• Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases

  2018cites this paper
• Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease

  2018cites this paper